Facilities

Our company values of innovation and excellence are reflected in our headquarters and state-of-the-art facilities in a repurposed Victorian waterworks building on the River Thames in Hampton, UK.

Our Locations

Innovating internationally

Touchlight is an international biotechnology company with two GMP manufacturing facilities, in Hampton, UK and San Sebastian, Spain.

Building 3

Hampton, UK

At our Hampton site, we manufacture Research, Toxicology and GMP-grade dbDNA™ as a critical starting material or Active Pharmaceutical Ingredient for Genetic Medicines. We are in the process of expanding our London-based manufacturing facilities to more than triple our manufacturing capacity, allowing us to deliver up to 1 kilogram of GMP dbDNA™ per month. (See details below.)

Facility overview
  • 4 GMP suites, expanding to 15
  • Quality system established, based on EU GMP Part II (in alignment with ICH Q7)
  • Facility is classified Grade D (ISO 8 / Class 100,000) in operation, is monitored and performs as Grade C (ISO 7 / Class 10,000) in accordance with ISO 14644-1 and US FED 209D
Services
  • Research grade DNA
  • Clinical grade DNA
  • Development services
  • Regulatory services
Touchlight San Sebastian

San Sebastian, Spain

At our San Sebastian site, we manufacture GMP dbDNA™ as a critical starting material for AAV.

Facility overview:
  • 4 suites, expanding to 11
  • Quality system established, based on EU GMP Part II (in alignment with ICH Q7)
  • Facility is classified Grade D (ISO 8 / Class 100,00) in operation, is monitored and performs as Grade C (ISO 7 / Class 10,000) in accordance with ISO 14644-1 and US FED 209D
Services
  • Research grade dbDNA™
  • Clinical grade dbDNA™
  • Custom and off-the-shelf AAV sequences

Take a tour of our state-of-the-art facilities. Explore our manufacturing facilities, housing the equipment and resources that power our groundbreaking dbDNA™ platform, and see the R&D laboratories and personnel fuelling our technological and applications pipeline solutions.

Large capacity, small footprint

We are in the process of expanding our London-based manufacturing facilities to more than triple our manufacturing capacity, allowing us to deliver up to 1 kilogram of GMP dbDNA™ per month. We anticipate our expanded facilities to be operational in Q2 2022.

Despite this huge capacity, which will enable us to deliver GMP dbDNA™ on a truly global scale, the small footprint of our benchtop equipment means the total facility footprint will be just 7,500 sq ft. This is a fraction of the space required by conventional bioreactor-based plasmid DNA manufacture.

Lab
Get in touch

We're here to help

For more information on how we can help with your project, please get in touch.

Contact us